T2* cardiovascular magnetic resonance in the management of thalassemia patients in Oman

Haematologica

Volumn 94, Issue 1, 2009, Pages 140-141

  Daar, Shahina ^a   Pathare, Anil V ^b   Jain, Rajeev ^a   Al Zadjali, Shoaib ^b   Pennell, Dudley J ^c  

^a SULTAN QABOOS UNIVERSITY   (Oman)

^b SULTAN QABOOS UNIVERSITY HOSPITAL   (Oman)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Heart; Iron overload; Magnetic resonance imaging; Oman; Thalassemia major

Indexed keywords

DEFERIPRONE; DEFEROXAMINE; FERRITIN;

CHELATION THERAPY; CORRELATION ANALYSIS; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; GENETIC SUSCEPTIBILITY; GENOTYPE; HEART EJECTION FRACTION; HEART FAILURE; HEART PROTECTION; HUMAN; IRON OVERLOAD; LETTER; MONOTHERAPY; NUCLEAR MAGNETIC RESONANCE; OMAN; SIDEROSIS; THALASSEMIA; ADOLESCENT; ADULT; AGE DISTRIBUTION; CHILD; FEMALE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CHILD; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; OMAN; THALASSEMIA;

EID: 58149216075     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.13845     Document Type: Letter

References (12)

1. Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, et al. Cardiovascular T2-star(T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001;22:2171-9.
2. Jensen PD. Evaluation of iron overload. Br J Haematol 2004;124:697-711.
3. Wood JC, Origa R, Agus A, Matta G, Coates TD, Galanello R. Onset of cardiac loading in pediatric patients with thalassaemia major. Haematologica 2008;93:917-20.
4. Bellenger NG, Burgess M, Ray SG, Coats A, Lahiri A, Cleland JGF, et al. Comparison of left ventricular ejection fraction and volumes in heart failure by two-dimensional echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance: are they interchangeable? The CHRISTMAS steering committee and investigators. Eur Heart J 2000;21:1387-96.
5. Tanner MA, Galanello R, Dessi C, Westwood MA, Smith GC, Nair SV, et al. Myocardial iron loading in patients with thalassaemia major on deferoxamine chelation. J Cardiovasc Magn Reson 2006;8:543-7.
6. Daar S, Pathare AV. Combined therapy with desferrioxamine and deferiprone in b thalassemia major patients with transfusional iron overload. Ann Hematol 2006;85:315-9.
7. Borgna-Pignatti C, Cappellini MD, De Stefano P, Del Vecchio GC, Forni GL, Gamberini MR, et al. Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major. Blood 2006;107:3733-7.
8. Tanner MA, Galanello R, Dessi C, Smith GC, Westwood MA, Agus A, et al. A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassaemia major using cardiovascular magnetic resonance. Circulation 2007;115:1876-84.
9. Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Liu PP, McGee A, et al. Survival in medically treated patients with homozygous β-thalassemia. N Engl J Med 1994;331:574-8.
10. Kolnagou A, Economides C, Eracleous E, Kontoghiorghes GJ. Low serum ferritin levels are misleading for detecting cardiac iron overload and increase the risk of cardiomyopathy in thalassemia patients. The importance of cardiac iron overload monitoring using magnetic resonance imaging T2 and T2*. Hemoglobin 2006;30:219-27.
11. Wu KH, Chang JG, Ho YJ, Wu SF, Peng CT. Glutathione S-transferase M1 gene polymorphisms are associated with cardiac iron deposition in patients with β-thalassemia major. Hemoglobin 2006;30:251-6.
12. Tanner MA, Galanello R, Dessi C, Smith GC, Westwood MA, Agus A, et al. Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction. J Cardiovasc Magn Reson 2008;10:12.